PRESS RELEASE: USFDA Authorizes DeltaRex-G as Platform Therapy

DeltaRex-G Expands USFDA Authorized Access to Breast Cancer, Pancreas Cancer, Osteosarcoma, and Soft Tissue Sarcoma

See: BLESSED PROTOCOL on clinicaltrials.gov